Luke Halpern is an intern with Pharmacy Times®.
The Growth of Biosimilars Continues to Create Hope for Lower Drug Costs
Perhaps the most significant development in the pharmaceutical industry in decades, crops of biosimilars are being approved and are ready for distribution. What lies next, in terms of legislation and the impact on pharmacists, remains to be seen.
2 Clarke Drive Cranbury, NJ 08512